Clive Meanwell
CIK 1204787 · EXECUTIVE CHAIRMAN · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDCO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
8 SYLVAN WAY
PARSIPPANY, NJ 07054
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GUTS | Director | 23,158 | $0.92 | $21.3K | $0 | 4 | 2026-06-11 |
| Metsera, Inc. (MTSR) Delisted | EXECUTIVE CHAIRMAN | 0 | $70.50 | $0 | $0 | 2 | 2025-11-13 |
| EQRx, Inc. (EQRXW) Delisted | Director | — | $0.05 | — | $0 | 4 | 2023-11-09 |
| IVVD | Director | — | $0.58 | — | $0 | 1 | 2023-05-25 |
| Invivyd, Inc. (ADGI) Delisted | Director | — | $4.64 | — | $0 | 1 | 2022-06-24 |
| Population Health Investment Co., Inc. (PHICW) Delisted | Chief Executive Officer | 11,300 | $0.00 | $3 | $160.7K | 1 | 2021-08-25 |
| MEDICINES CO /DE (MDCO) Delisted | Chief Innovation Officer | 0 | — | — | -$37.40M | 97 | 2020-01-06 |
| ENDO HEALTH SOLUTIONS INC. (ENDP) Delisted | Director | 11,855 | $0.29 | $3.5K | $0 | 4 | 2010-03-16 |
Recent Filings · Page 7 of 12
114 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-05-02 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −7,500 | -$251.0K | EDGAR |
| 2013-04-04 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −7,500 | -$250.3K | EDGAR |
| 2013-03-05 | MEDICINES CO /DE (MDCO) Delisted | Mixed | +58,328 | -$226.1K | EDGAR |
| 2013-02-26 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −12,303 | -$383.5K | EDGAR |
| 2013-02-22 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −8,292 | -$268.8K | EDGAR |
| 2013-02-21 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −6,232 | -$198.4K | EDGAR |
| 2013-02-05 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −7,500 | -$224.2K | EDGAR |
| 2013-01-17 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −2,500 | -$75.0K | EDGAR |
| 2013-01-04 | MEDICINES CO /DE (MDCO) Delisted | Sell (S) | −5,000 | -$121.1K | EDGAR |
| 2012-11-28 | MEDICINES CO /DE (MDCO) Delisted | Mixed | — | -$75.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.